Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity

Cancer Gene Therapy

Volumn 15, Issue 1, 2008, Pages 51-59

  Tanaka, F ^a   Tominaga, K ^a   Shiota, M ^a   Ochi, M ^a   Kuwamura, H ^a   Tanigawa, T ^a   Watanabe, T ^a   Fujiwara, Y ^a   Oshitani, N ^a   Higuchi, K ^a   Iwao, H ^a   Arakawa, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Interleukin 10; Peritoneal dissemination; Peritoneal mesothelial cells

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CACHEXIA; CANCER CELL; CANCER GENE THERAPY; CANCER SURVIVAL; CELL ISOLATION; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; MALE; MESOTHELIUM CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM; PERITONEUM CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; RAT; STOMACH CANCER; SURVIVAL TIME; THERAPY EFFECT; TUMOR VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CACHEXIA; EPITHELIUM; HUMANS; INTERLEUKIN-10; LAC OPERON; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; RATS; RATS, WISTAR; STOMACH NEOPLASMS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS); MUS;

EID: 37149034175     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7701104     Document Type: Article

References (35)

1. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
2. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
3. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822.
4. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-1555.
5. Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res 1999; 19: 697-703.
6. Cervenak L, Morbidelli L, Donati D, Donnini S, Kambayashi T, Wilson JL et al. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood 2000; 96: 2568-2573.
7. Kohno T, Mizukami H, Suzuki M, Saga Y, Takei Y, Shimpo M et al. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res 2003; 63: 5091-5094.
8. Stearns ME, Rhim J, Wang M. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 1999; 5: 189-196.
9. Kundu N, Beaty TL, Jackson MJ, Fulton AM. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J Natl Cancer Inst 1996; 88: 536-541.
10. Zheng LM, Ojclus DM, Garaud F, Roth C, Maxwell E, Li Z et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med 1996; 184: 579-584.
11. Berman RM, Susuki T, Tahara H, Robbins PD, Narula SK, Lotze MT. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J Immunol 1996; 157: 231-238.
12. Kundu N, Fulton AM. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Cell Immunol 1997; 180: 55-61.
13. Di Carlo E, Coletti A, Modesti A, Giovarelli M, Forni G, Musiani P. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Eur Cytokine Netw 1998; 9: 61-68.
14. Kundu N, Dorsey R, Jackson MJ, Guiterrez P, Wilson K, Fu S et al. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide. Int J Cancer 1998; 76: 713-719.
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
16. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154: 5492-5499.
17. Kokura S, Yoshida N, Ishikawa T, Higashihara H, Sakamoto N, Takagi T et al. Interleukin-10 plasmid DNA inhibits subcutaneous tumor growth of Colon26 adenocarcinoma in mice. Cancer Lett 2005; 218: 171-179.
18. Benevolo M, Mottolese M, Cosimelli M, Tedesco M, Giannarelli D, Vasselli S et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 1998; 16: 3406-3411.
19. Gosselin R, Berndt W. Diffusional transport of solutes through mesentery and peritoneum. J Theor Biol 1962; 3: 487.
20. Topley N, Jorres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNF α. Kidney Int 1993; 43: 226-233.
21. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hart M et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-α, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis 1993; 168: 1702-1710.
22. Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G et al. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992; 80: 2835-2842.
23. Jayne DG, Perry SL, Morrison E, Farmery SM, Guillou PJ. Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastasis. Br J Cancer 2000; 82: 1233-1238.
24. Sako A, Kitayama J, Yamaguchi H, Kaisaki S, Suzuki H, Fukatsu K et al. Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. J Surg Res 2003; 115: 113-120.
25. Balabanian K, Foussat A, Bouchet-Delbos L, Couderc J, Krzysiek R, Amara A et al. Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 2002; 99: 427-436.
26. Sako A, Kitayama J, Koyama H, Ueno H, Uchida H, Hamada H et al. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Cancer Res 2004; 64: 3624-3628.
27. Fujikawa K, Takai K, Suga A, Naito K, Ohata A, Nakasone S et al. Expression of mRNA for growth factors and extracellular matrix proteins after injury to cultured peritoneal cells: does the healing process contribute to peritoneal ultrastructural alteration? J Artif Organs 2003; 6: 253-259.
28. Robson RL, McLoughlin RM, Witowski J, Loetscher P, Wilkinson TS, Jones SA et al. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-γ controls neutrophil migration across the mesothelium in vitro and in vivo. J Immunol 2001; 167: 1028-1038.
29. Takakuwa T, Endo S, Shirakura Y, Yokoyama M, Tamatani M, Tohyama M et al. Interleukin-10 gene transfer improves the survival rate of mice inoculated with Escherichia coli. Crit Care Med 2000; 28: 2685-2689.
30. Kuwamura H, Tominaga K, Shiota M, Ashida R, Nakao T, Sasaki E et al. Growth inhibition of colon cancer cells by transfection of dominant-negative apoptosis signal-regulating kinase-1. Oncol Rep 2007; 17: 781-786.
31. Suto R, Tominaga K, Mizuguchi H, Sasaki E, Higuchi K, Kim S et al. Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer. Gene Ther 2004; 11: 187-193.
32. Fujiki F, Mukaida N, Hirose K, Ishida H, Harada A, Ohno S et al. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer. Cancer Res 1997; 57: 94-99.
33. Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A et al. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 1995; 155: 3112-3123.
34. Zeni F, Tardy B, Vindimian M, Comtet C, Page Y, Cusey I et al. High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993; 17: 218-223.
35. Zebrowski BK, Liu W, Ramirez K, Akagi Y, Mills GB, Ellis LM. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 1999; 6: 373-378.